Lallemand to Showcase Yeast Protein and Savory Applications at IFIA Japan 2026

Lallemand Bio-Ingredients is taking a practical bet on yeast protein: it will use IFIA Japan 2026 to sell functionality, not just protein numbers. The company will show Engevita HiPRO Beyond at Booth 1F25 under SHOKO Co., Ltd., and the pitch is built around a neutral, very mildly flavored ingredient that can move into both sweet and savory systems without forcing formulators to fight taste first.

That matters because the ingredient is not being framed as a standalone novelty. Lallemand says Engevita HiPRO Beyond comes from baker’s yeast, Saccharomyces cerevisiae, and contains a minimum of 80% protein. The company also describes it as gluten-free, vegan, allergen-free, non-GMO and a complete protein with all essential and branched-chain amino acids. Just as important for real-world use, Lallemand’s food applications messaging says the ingredient has a very clean taste and can be used seamlessly in food applications, which is exactly the kind of promise that gets attention when protein fortification starts running into sensory limits.

The Tokyo show is a smart place to make that case. IFIA Japan 2026 runs May 27 to 29 and the official event site says it expects about 30,000 visitors. For ingredient suppliers, that kind of traffic is less about spectacle than education, especially in a market that puts a premium on clean taste, functionality and process compatibility. Lallemand’s broader bio-ingredients business already specializes in inactive yeast and yeast extract for savory and nutritional markets, and its savory messaging leans on umami, kokumi and sodium-reduction support. Putting yeast protein next to those tools makes the company’s argument more coherent: formulators do not just want protein enrichment, they want ingredients that help a product taste better or at least stay out of the way.

That strategy also fits where yeast protein is heading. Lallemand has already positioned Engevita HiPRO Beyond for dairy alternatives and hybrid dairy products, and the company’s Swiss affiliate Danstar Ferment backed Revyve’s €24 million Series B round, a sign that it sees yeast-based proteins as a category with legs. At IFIA Japan, the message will be simple: the winners in alternative ingredients may be the ones that solve texture and flavor first, then let the protein claim follow.